Profile
Mr. Yun Fei Chen is on the Board of Directors at Kintor Pharmaceutical Ltd., CareRay Digital Medical Technology Co., Ltd., Suzhou Kintor Pharmaceuticals, Inc. and Suzhou GenePharma Co., Ltd. He received his graduate degree from Wuhan University, a graduate degree from Cheung Kong Graduate School of Business and an MBA from Cheung Kong Graduate School of Business.
Yun Fei Chen active positions
| Companies | Position | Start |
|---|---|---|
| CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD. | Director/Board Member | 16/05/2025 |
| KINTOR PHARMACEUTICAL LIMITED | Director/Board Member | 11/12/2025 |
Suzhou GenePharma Co., Ltd.
Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Offers core technologies of siRNA chemical synthesis, RNA monomer synthesis, custom and chemically-modified siRNA oligo synthesis, nucleic acid fluorescent labeling, and many nucleotide chemical modification technologies | Director/Board Member | 19/07/2018 |
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of oncological and cardiovascular | Director/Board Member | 16/12/2020 |
Training of Yun Fei Chen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Wuhan University
Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cheung Kong Graduate School of Business
Cheung Kong Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CareRay Digital Medical Technology Co., Ltd.
CareRay Digital Medical Technology Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Manufactures medical equipment | Electronic Technology |
Suzhou GenePharma Co., Ltd.
Suzhou GenePharma Co., Ltd. BiotechnologyHealth Technology Offers core technologies of siRNA chemical synthesis, RNA monomer synthesis, custom and chemically-modified siRNA oligo synthesis, nucleic acid fluorescent labeling, and many nucleotide chemical modification technologies | Health Technology |
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of oncological and cardiovascular | Health Technology |
Kintor Pharmaceutical Ltd.
Kintor Pharmaceutical Ltd. BiotechnologyHealth Technology Provides research and development of prostate, breast & liver cancer drugs services | Health Technology |
- Stock Market
- Insiders
- Yun Fei Chen
















